Literature DB >> 1575028

Obstructive sleep apnea in patients with pharyngeal tumours.

U Höijer1, H Ejnell, J Hedner.   

Abstract

Six consecutive patients with pharyngeal tumours were investigated regarding disordered breathing during sleep. In addition to pulse oximetry, the investigations involved oral and nasal airflow as well as thoracic respiratory movements in four of the patients in whom the oxygen desaturation index (ODI, number of desaturations per hour of estimated sleep) was on average 24 (range 10-58). An almost total predominance of obstructive apnea was found in evaluated cases. In the 2 cases in whom only pulse oximetry was performed, numerous desaturations were found throughout the night (ODI 19 and 88, respectively). The overnight minimum oxygen saturation before treatment varied but was below 80% in 5 of the 6 patients (range less than 50-89%). On reinvestigation (n = 5) 3-4 months after treatment (radical surgery or, in one case, nasal continuous positive airway pressure (CPAP)), desaturations were totally or almost totally abolished in all patients. It is concluded that the obstructive sleep apnea syndrome may be a common finding in patients with tumours in the pharyngeal region. Radical surgery and/or nasal CPAP may result in complete disappearance of the disordered breathing during sleep in these patients.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1575028     DOI: 10.3109/00016489209100795

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  2 in total

1.  Obstructive sleep apnea caused by carotid body tumor: case report.

Authors:  Tarif Smadi; M Ali Raza; B Tucker Woodson; Rose A Franco
Journal:  J Clin Sleep Med       Date:  2007-08-15       Impact factor: 4.062

Review 2.  Systematic review of sleep disorders in cancer patients: can the prevalence of sleep disorders be ascertained?

Authors:  Julie L Otte; Janet S Carpenter; Shalini Manchanda; Kevin L Rand; Todd C Skaar; Michael Weaver; Yelena Chernyak; Xin Zhong; Christele Igega; Carol Landis
Journal:  Cancer Med       Date:  2014-11-30       Impact factor: 4.452

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.